Skip to content
2000
Volume 23, Issue 2
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

A new COVID-19 variant that no one currently wants has emerged with the start of the new year. Omicron, which was first discovered in November of last year, was only just beginning to be understood when another strain uncovered in France made headlines. On January 4, 2022, news of the variant exploded on social media, but cases of what is now known as variant B.1.640.2 (IHU) were initially discovered about two months prior. Evidence is still being gathered, but internet misinformation regarding the latest coronavirus variety is already rampant, as it was with Omicron. The majority of existing vaccines target SARS-spike CoV-2's protein, which the virus utilizes to enter and infect cells. Epidemiologists and virologists worldwide are concerned about the virus' spike protein, which plays a key role in how your body identifies and reacts to the virus. Spike proteins are produced, recognized, and defended against by our immune system. Your body and the vaccines you have had injected into your system have a far harder time fighting the virus when the amino acids in a protein are altered or removed.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526522666220831101802
2023-03-01
2024-10-10
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526522666220831101802
Loading
  • Article Type: Other
Keyword(s): COVID-19; IHU; mutations; spike proteins; variant B.1.640.2; WHO
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test